314 related articles for article (PubMed ID: 18393080)
1. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment.
Astals M; Domingo-Salvany A; Buenaventura CC; Tato J; Vazquez JM; Martín-Santos R; Torrens M
Subst Use Misuse; 2008; 43(5):612-32. PubMed ID: 18393080
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric comorbidity and gender difference among treatment-seeking heroin abusers in Taiwan.
Chiang SC; Chan HY; Chang YY; Sun HJ; Chen WJ; Chen CK
Psychiatry Clin Neurosci; 2007 Feb; 61(1):105-11. PubMed ID: 17239047
[TBL] [Abstract][Full Text] [Related]
3. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
Frei A; Rehm J;
Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric comorbidity in methadone maintained patients.
Mason BJ; Kocsis JH; Melia D; Khuri ET; Sweeney J; Wells A; Borg L; Millman RB; Kreek MJ
J Addict Dis; 1998; 17(3):75-89. PubMed ID: 9789161
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric comorbidity in young heroin users.
Rodríguez-Llera MC; Domingo-Salvany A; Brugal MT; Silva TC; Sánchez-Niubó A; Torrens M;
Drug Alcohol Depend; 2006 Sep; 84(1):48-55. PubMed ID: 16388919
[TBL] [Abstract][Full Text] [Related]
6. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
Maremmani I; Pani PP; Pacini M; Perugi G
J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
[TBL] [Abstract][Full Text] [Related]
7. The role of antisocial and borderline personality features in substance dependence among incarcerated females.
Chapman AL; Cellucci T
Addict Behav; 2007 Jun; 32(6):1131-45. PubMed ID: 16962249
[TBL] [Abstract][Full Text] [Related]
8. Psychiatric comorbidity is associated with drug use and HIV risk in syringe exchange participants.
Disney E; Kidorf M; Kolodner K; King V; Peirce J; Beilenson P; Brooner RK
J Nerv Ment Dis; 2006 Aug; 194(8):577-83. PubMed ID: 16909065
[TBL] [Abstract][Full Text] [Related]
9. Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity.
Maremmani I; Zolesi O; Aglietti M; Marini G; Tagliamonte A; Shinderman M; Maxwell S
J Addict Dis; 2000; 19(2):29-41. PubMed ID: 10809518
[TBL] [Abstract][Full Text] [Related]
10. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
[TBL] [Abstract][Full Text] [Related]
11. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance.
Ngo HT; Tait RJ; Hulse GK
J Psychopharmacol; 2011 Jun; 25(6):774-82. PubMed ID: 20360157
[TBL] [Abstract][Full Text] [Related]
12. Effects of psychiatric comorbidity on treatment outcome in patients undergoing diamorphine or methadone maintenance treatment.
Schäfer I; Eiroa-Orosa FJ; Verthein U; Dilg C; Haasen C; Reimer J
Psychopathology; 2010; 43(2):88-95. PubMed ID: 20068379
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV.
Torrens M; Serrano D; Astals M; Pérez-Domínguez G; Martín-Santos R
Am J Psychiatry; 2004 Jul; 161(7):1231-7. PubMed ID: 15229056
[TBL] [Abstract][Full Text] [Related]
14. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis).
Maremmani I; Pacini M; Lubrano S; Perugi G; Tagliamonte A; Pani PP; Gerra G; Shinderman M
Eur Addict Res; 2008; 14(3):134-42. PubMed ID: 18552489
[TBL] [Abstract][Full Text] [Related]
16. The Addiction Severity Index medical and psychiatric composite scores measure similar domains as the SF-36 in substance-dependent veterans: concurrent and discriminant validity.
Calsyn DA; Saxon AJ; Bush KR; Howell DN; Baer JS; Sloan KL; Malte CA; Kivlahan DR
Drug Alcohol Depend; 2004 Nov; 76(2):165-71. PubMed ID: 15488340
[TBL] [Abstract][Full Text] [Related]
17. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS).
Darke S; Williamson A; Ross J; Teesson M; Lynskey M
Drug Alcohol Depend; 2004 Apr; 74(1):77-83. PubMed ID: 15072810
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of mental and physical health disorders among older methadone patients.
Rosen D; Smith ML; Reynolds CF
Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in methadone maintenance patients with untreated hepatitis C virus infection.
Batki SL; Canfield KM; Smyth E; Ploutz-Snyder R
Drug Alcohol Depend; 2009 May; 101(3):176-82. PubMed ID: 19233573
[TBL] [Abstract][Full Text] [Related]
20. [Personality disorders in a clinical sample of Cannabis dependent young adults].
Watzke AB; Schmidt CO; Zimmermann J; Preuss UW
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):600-5. PubMed ID: 18833505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
